For research use only. Not for therapeutic Use.
RAD51-IN-5 is a potent inhibitor of RAD51. RAD51 is a eukaryote gene. RAD51-IN-5 has the potential for the research of conditions involving mitochondrial defects (extracted from patent WO2021164746A1, compound 3)[1].
| Catalog Number | I043715 |
| CAS Number | 2690367-19-0 |
| Synonyms | propan-2-yl N-[4-[2-[4-(propan-2-yloxycarbonylamino)cyclohexyl]-1,3-thiazol-5-yl]-3-(propan-2-ylsulfonimidoyl)phenyl]carbamate |
| Molecular Formula | C26H38N4O5S2 |
| Purity | ≥95% |
| InChI | InChI=1S/C26H38N4O5S2/c1-15(2)34-25(31)29-19-9-7-18(8-10-19)24-28-14-22(36-24)21-12-11-20(30-26(32)35-16(3)4)13-23(21)37(27,33)17(5)6/h11-19,27H,7-10H2,1-6H3,(H,29,31)(H,30,32) |
| InChIKey | IFAJQXQNZPNAHT-UHFFFAOYSA-N |
| SMILES | CC(C)OC(=O)NC1CCC(CC1)C2=NC=C(S2)C3=C(C=C(C=C3)NC(=O)OC(C)C)S(=N)(=O)C(C)C |
| Reference | [1]. Peng Gu, et al. Substituted aryl compound. Patent WO2021164746A1. |
